Arcutis Biotherapeutics
ARQT
ARQT
78 hedge funds and large institutions have $1.15B invested in Arcutis Biotherapeutics in 2020 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 33 increasing their positions, 12 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
13% more capital invested
Capital invested by funds: $1.02B → $1.15B (+$135M)
2.88% more ownership
Funds ownership: 91.03% → 93.91% (+2.9%)
Holders
78
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$39.4M | |
| 2 | +$23.6M | |
| 3 | +$23.4M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$23M |
| 5 |
State Street
Boston,
Massachusetts
|
+$16.1M |
Top Sellers
| 1 | -$20.5M | |
| 2 | -$6.92M | |
| 3 | -$4.76M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$1.68M |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
-$696K |